WOLVERINE TRADING, LLC - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 75 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.

Quarter-by-quarter ownership
WOLVERINE TRADING, LLC ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$28,000
-46.2%
16,900
-59.8%
0.00%
Q2 2022$52,000
-35.0%
42,010
-10.0%
0.00%
Q1 2022$80,000
+207.7%
46,659
+282.5%
0.00%
Q4 2021$26,000
-63.4%
12,200
-40.5%
0.00%
Q2 2021$71,000
-33.0%
20,500
-60.6%
0.00%
Q1 2021$106,000
+186.5%
52,072
+219.5%
0.00%
Q4 2020$37,000
-14.0%
16,300
+25.4%
0.00%
Q3 2020$43,000
+4.9%
13,000
-2.8%
0.00%
Q2 2020$41,000
-6.8%
13,376
-39.7%
0.00%
Q1 2020$44,000
-4.3%
22,200
+35.4%
0.00%
Q4 2019$46,000
-66.9%
16,400
-57.0%
0.00%
Q3 2019$139,0000.0%38,171
+14.6%
0.00%
Q2 2019$139,000
-51.2%
33,300
-40.2%
0.00%
-100.0%
Q1 2019$285,000
+0.4%
55,700
-26.0%
0.00%
Q4 2018$284,000
-42.0%
75,239
-7.6%
0.00%
Q3 2018$490,000
+76.3%
81,427
+39.2%
0.00%
Q2 2018$278,0000.0%58,5000.0%0.00%
Q1 2018$278,000
+38.3%
58,500
-38.0%
0.00%
-100.0%
Q3 2017$201,000
-9.0%
94,407
+1.1%
0.00%0.0%
Q2 2017$221,000
+140.2%
93,366
+23.2%
0.00%
Q3 2016$92,00075,7560.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 169,578$222,0000.08%
Geneos Wealth Management Inc. 478,067$626,0000.03%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$16,0000.01%
Atria Wealth Solutions, Inc. 281,700$369,0000.01%
Vivaldi Capital Management LP 17,078$22,0000.01%
OSAIC HOLDINGS, INC. 1,284,481$1,684,0000.00%
Ameritas Advisory Services, LLC 45,302$59,0000.00%
CENTAURUS FINANCIAL, INC. 20,947$27,0000.00%
Summit Trail Advisors, LLC 23,855$31,0000.00%
WEDBUSH SECURITIES INC 27,998$37,0000.00%
View complete list of GALECTIN THERAPEUTICS INC shareholders